160 related articles for article (PubMed ID: 1087092)
1. Clinical significance of anti-insulin-antibodies.
Andersen OO
Acta Endocrinol Suppl (Copenh); 1976; 205():231-40. PubMed ID: 1087092
[TBL] [Abstract][Full Text] [Related]
2. [Proceedings: Formation of anti-insulin antibodies IgG in diabetic patients treated with conventional insulin monocomposed or monospecific].
Weber HU; Sourisseau D; Zahnd GR
Helv Med Acta; 1974 May; 37(5-6):367. PubMed ID: 4410557
[No Abstract] [Full Text] [Related]
3. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
Anderson OO
Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
[TBL] [Abstract][Full Text] [Related]
4. Insulin receptor antibodies in diabetes mellitus.
Batarseh H; Thompson RA; Odugbesan O; Barnett AH
Clin Exp Immunol; 1988 Jan; 71(1):85-90. PubMed ID: 3280181
[TBL] [Abstract][Full Text] [Related]
5. Serological analysis of human IgG and IgE anti-insulin antibodies by solid-phase radioimmunoassays.
Hamilton RG; Rendell M; Adkinson NF
J Lab Clin Med; 1980 Dec; 96(6):1022-36. PubMed ID: 7000933
[No Abstract] [Full Text] [Related]
6. Anti-insulin IgE in diabetics.
Kumar D
J Clin Endocrinol Metab; 1977 Dec; 45(6):1159-64. PubMed ID: 591613
[TBL] [Abstract][Full Text] [Related]
7. [The nuclear medical determination of immunoglobulin E in vitro for diabetics (author's transl)].
Spesivzeva VG; Zubovskij GA; Dreval AV; Verescagina GV
Radiol Diagn (Berl); 1978 Aug; 19(4):546-51. PubMed ID: 734104
[No Abstract] [Full Text] [Related]
8. Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients.
Emanuelli G; Gatti G; Calcamuggi G; Anfossi G; Cotto A; Marcarino C; Camussi G; Ottone G
Panminerva Med; 1981; 23(2):81-8. PubMed ID: 7033894
[No Abstract] [Full Text] [Related]
9. High and low affinity insulin antibodies.
Kerp L; Kasemir H
Acta Endocrinol Suppl (Copenh); 1976; 205():211-22. PubMed ID: 1087091
[No Abstract] [Full Text] [Related]
10. Insulin antibodies and the control of diabetes.
Dixon K; Exon PD; Malins JM
Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
[TBL] [Abstract][Full Text] [Related]
11. Insulin antibodies in diabetics receiving a single type of insulin.
Mincu I; Cheţa D
Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
[TBL] [Abstract][Full Text] [Related]
12. Study on the insulin-binding capacity of blood serum by a cellulose adsorption method.
Baranyi E; Tamás G; Bojta J
Acta Med Acad Sci Hung; 1975; 32(2):173-81. PubMed ID: 798462
[TBL] [Abstract][Full Text] [Related]
13. Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man.
Flier JS; Kahn CR; Jarrett DB; Roth J
J Clin Invest; 1976 Dec; 58(6):1442-9. PubMed ID: 993353
[TBL] [Abstract][Full Text] [Related]
14. Exogenous insulin needs. Relationship with duration of diabetes, C-peptidemia, insulin antibodies, and retinopathy.
Haumont D; Dorchy H; Toussaint D; Despontin M
Helv Paediatr Acta; 1982 May; 37(2):143-50. PubMed ID: 7047466
[TBL] [Abstract][Full Text] [Related]
15. Determination of insulin antibodies.
Kansal PC; Bandisode MS; Boshell BR
Horm Metab Res; 1979 Mar; 11(3):187-9. PubMed ID: 447197
[TBL] [Abstract][Full Text] [Related]
16. [Levels of immunoglobulins A, M, G, E and titers of complement and insulin antibodies in young diabetic patients].
Iuldashev AK
Ter Arkh; 1980; 52(8):67-70. PubMed ID: 7256593
[No Abstract] [Full Text] [Related]
17. [Late complications of diabetes mellitus-consequence of immunologic reactions?].
Bemm H; Lohmann D
Allerg Immunol (Leipz); 1974-1975; 20-21(1):15-20. PubMed ID: 4282823
[TBL] [Abstract][Full Text] [Related]
18. The immunogenicity of insulin preparations.
Chance RE; Root MA; Galloway JA
Acta Endocrinol Suppl (Copenh); 1976; 205():185-98. PubMed ID: 793278
[TBL] [Abstract][Full Text] [Related]
19. [Monocomponent insulin: general considerations].
Rodriguez-Miñon JL; Rios MS
Journ Annu Diabetol Hotel Dieu; 1978; ():109-22. PubMed ID: 651088
[No Abstract] [Full Text] [Related]
20. Diagnostic algorithm and management of immune-mediated complications associated with subcutaneous insulin therapy.
Jaeger C; Eckhard M; Brendel MD; Bretzel RG
Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):416-21. PubMed ID: 15372360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
